| Financial Year |
March 31 2023 |
| Monetary Funds |
340,209,837.29 |
| Held-for-trading Financial Assets |
58,234,951.11 |
| Notes Receivable |
5,237,120.00 |
| Accounts Receivable |
409,850,267.00 |
| Advances to Suppliers |
1,555,674.57 |
| Other Receivables |
12,223,995.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
256,500.00 |
| Dividend Receivable |
-- |
| Inventories |
200,833,234.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,889,244.65 |
| Total Current Assets |
2,161,836,432.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
43,641,745.54 |
| Long-term Equity Investment |
14,270,788.76 |
| Investment Properties |
-- |
| Fixed Assetes |
34,785,426.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,022.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,762,336.00 |
| Deferred Income Tax Assets |
41,223,635.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
289,024,412.53 |
| Total Assets |
2,450,860,845.08 |
| Short-Term Loans |
400,468,662.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,589,103.38 |
| Accounts Payable |
419,979,420.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,875,824.89 |
| Taxes Payable |
15,319,264.55 |
| Interest Payable |
-- |
| Dividend Payable |
4,839,085.40 |
| Other payables |
26,806,225.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,739,634.52 |
| Other Current Liabilities |
14,494,755.58 |
| Sub-Total of Current Liabilities |
932,568,551.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
78,000.00 |
| Deferred Income Tax Liabilities |
476,867.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,309,780.72 |
| Total Liabilities |
944,878,332.44 |
| Paid-In Capital(Or Share Stock) |
277,497,822.00 |
| Capital Surplus |
498,715,486.41 |
| Surplus Reserve |
95,480,954.62 |
| LESS:Treasury Stock |
15,886,000.00 |
| Undistributed Profits |
647,391,987.07 |
| Minority Stockholder's Interest |
2,782,262.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,503,200,250.10 |
| Owner's Equity（Stockholder's Equity） |
1,505,982,512.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,450,860,845.08 |
